66 related articles for article (PubMed ID: 1735313)
21. Differential Immune Activating, Anti-Inflammatory, and Regenerative Properties of the Aqueous, Ethanol, and Solid Fractions of a Medicinal Mushroom Blend.
Davis R; Taylor A; Nally R; Benson KF; Stamets P; Jensen GS
J Inflamm Res; 2020; 13():117-131. PubMed ID: 32158252
[TBL] [Abstract][Full Text] [Related]
22. Practical Application of "About Herbs" Website: Herbs and Dietary Supplement Use in Oncology Settings.
Hou YN; Deng G; Mao JJ
Cancer J; 2019; 25(5):357-366. PubMed ID: 31567464
[TBL] [Abstract][Full Text] [Related]
23. Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? a systematic review and network meta-analysis.
Ma Y; Wu X; Yu J; Zhu J; Pen X; Meng X
Oncotarget; 2017 Oct; 8(51):89108-89118. PubMed ID: 29179503
[TBL] [Abstract][Full Text] [Related]
24. Postoperative adjuvant chemotherapy in rectal cancer operated for cure.
Petersen SH; Harling H; Kirkeby LT; Wille-Jørgensen P; Mocellin S
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD004078. PubMed ID: 22419291
[TBL] [Abstract][Full Text] [Related]
25. Natural products for cancer prevention.
Greenlee H
Semin Oncol Nurs; 2012 Feb; 28(1):29-44. PubMed ID: 22281308
[TBL] [Abstract][Full Text] [Related]
26. Immunomodulatory dietary polysaccharides: a systematic review of the literature.
Ramberg JE; Nelson ED; Sinnott RA
Nutr J; 2010 Nov; 9():54. PubMed ID: 21087484
[TBL] [Abstract][Full Text] [Related]
27. PSK may suppress CD57(+) T cells to improve survival of advanced gastric cancer patients.
Akagi J; Baba H
Int J Clin Oncol; 2010 Apr; 15(2):145-52. PubMed ID: 20229169
[TBL] [Abstract][Full Text] [Related]
28. Trametes versicolor mushroom immune therapy in breast cancer.
Standish LJ; Wenner CA; Sweet ES; Bridge C; Nelson A; Martzen M; Novack J; Torkelson C
J Soc Integr Oncol; 2008; 6(3):122-8. PubMed ID: 19087769
[TBL] [Abstract][Full Text] [Related]
29. Herbs and other botanicals in cancer patient care.
Cassileth B; Yeung KS; Gubili J
Curr Treat Options Oncol; 2008 Jun; 9(2-3):109-16. PubMed ID: 18612829
[TBL] [Abstract][Full Text] [Related]
30. The pharmacological potential of mushrooms.
Lindequist U; Niedermeyer TH; Jülich WD
Evid Based Complement Alternat Med; 2005 Sep; 2(3):285-99. PubMed ID: 16136207
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials.
Sakamoto J; Morita S; Oba K; Matsui T; Kobayashi M; Nakazato H; Ohashi Y;
Cancer Immunol Immunother; 2006 Apr; 55(4):404-11. PubMed ID: 16133112
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study.
Ohwada S; Ikeya T; Yokomori T; Kusaba T; Roppongi T; Takahashi T; Nakamura S; Kakinuma S; Iwazaki S; Ishikawa H; Kawate S; Nakajima T; Morishita Y
Br J Cancer; 2004 Mar; 90(5):1003-10. PubMed ID: 14997197
[TBL] [Abstract][Full Text] [Related]
33. Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up.
Ito K; Nakazato H; Koike A; Takagi H; Saji S; Baba S; Mai M; Sakamoto J; Ohashi Y;
Int J Colorectal Dis; 2004 Mar; 19(2):157-64. PubMed ID: 13680286
[TBL] [Abstract][Full Text] [Related]
34. Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs.
Zhang H; Morisaki T; Matsunaga H; Sato N; Uchiyama A; Hashizume K; Nagumo F; Tadano J; Katano M
Clin Exp Metastasis; 2000; 18(4):343-52. PubMed ID: 11448066
[TBL] [Abstract][Full Text] [Related]
35. HLA-A2 antigen status predicts metastasis and response to immunotherapy in gastric cancer.
Ogoshi K; Tajima T; Mitomi T; Makuuchi H; Tsuji K
Cancer Immunol Immunother; 1997 Oct; 45(1):53-9. PubMed ID: 9353427
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K.
Yefenof E; Gafanovitch I; Oron E; Bar M; Klein E
Cancer Immunol Immunother; 1995 Dec; 41(6):389-96. PubMed ID: 8635197
[TBL] [Abstract][Full Text] [Related]
37. Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide.
Kato M; Hirose K; Hakozaki M; Ohno M; Saito Y; Izutani R; Noguchi J; Hori Y; Okumoto S; Kuroda D
Cancer Immunol Immunother; 1995 Mar; 40(3):152-6. PubMed ID: 7728773
[TBL] [Abstract][Full Text] [Related]
38. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).
Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
Dis Colon Rectum; 1992 Feb; 35(2):123-30. PubMed ID: 1735313
[TBL] [Abstract][Full Text] [Related]
39. [Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum].
Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2241-9. PubMed ID: 2500070
[TBL] [Abstract][Full Text] [Related]
40. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
